Abstract. The incidence of malignant tumors increases with age. This may be due to the duration of carcinogenesis or age related changes providing a favorable environment for tumor formation. Aging is associated with molecular, cellular and physiological events that influence carcinogenesis and cancer growth. Physiologic cell proliferation, differentiation, and aging can result in cell death. However, under the influence of exogenous or endogenous factors cells can undergo pathologic dedifferentiation, immortalization, and neoplastic clone formation. The effects of age have been recognized in both animal and human malignancies. These processes can result in cellular senescence as a barrier to tumorigenesis. Inducing senescence is an important outcome for the successful treatment of cancers particularly those resistant to apoptosis. Senescence is associated with polyploidy in several human cell lines. Polyploid cells are dangerous in that they can undergo aberrant mitoses giving rise to unstable progeny. Polyploid cells have been shown to escape senescence and divide. We examined the effects of aging on squamous cell carcinoma formation in a mouse model. Chronologically aged mice experience shorter tumor latency periods than wildtype animals. Tumors in aged mice were poorly vascularized, necrotic, and produced significantly fewer cervical lymph node metastases. Vascular endothelial growth factor expression was similar in primary tumors from young and old mice, but microvessel density was significantly reduced in tumors arising in aged mice. These results indicate that host response to angiogenic factors inhibit tumor growth and metastasis of head and neck cancer.
Introduction
The incidence of malignant tumors increases with age (1) . This may be due to the duration of carcinogenesis or age related changes providing a favorable environment for tumor formation (2) . Aging is associated with molecular, cellular and physiological events that influence carcinogenesis and cancer growth (3) . Physiologic cell proliferation, differentiation, and aging can result in cell death (4) . However, under the influence of exogenous or endogenous factors cells can undergo pathologic dedifferentiation, immortalization, and neoplastic clone formation (5) . The majority of tumors are caused by environmental and lifestyle related factors (6) . There is similarity between aging and carcinogenesis via systemic regulation at the physiologic level. In this regard, immunosuppression is a common feature of aging and carcinogenesis (7) . Dysfunctional T lymphocytes have been characterized in elderly humans (8) . Alterations of immune surveillance may contribute to age associated cancer. Decreased specific T cell responses to tumor antigens may explain this phenomenon (9) .
The effects of age have been recognized in both animal and human malignancies (10) . DNA damage is believed to be high in human cells. Mechanisms of DNA repair have evolved to deal with DNA damage. These processes can result in cellular senescence as a barrier to tumorigenesis (11) . Many tumor cells have the ability to undergo senescence in vitro (12) . Cancer cells exposed to DNA damaging agents undergo permanent cell cycle arrest and acquire a phenotype similar to that observed in senescence of normal human cells (13) . Senescent cells have been reported in breast cancer biopsies and those from lung cancer patients receiving chemotherapy (14, 15) . Inducing senescence is an important outcome for the successful treatment of cancers particularly those resistant to apoptosis (16) . Cancer cells can be blocked in G2 or bypass cell cycle checkpoints and undergo endo-reduplication. Senescence is associated with polyploidy in several human cell lines (17) . Polyploid cells are dangerous in that they can undergo aberrant mitoses giving rise to unstable progeny (18) . Polyploid cells have been shown to escape senescence and divide (19) .
To determine the effects of aging on a mouse head and neck cancer model (20) , we compared the phenotypes of chemically induced head and neck cancer in mice that began the tumor induction protocol at 1 month and 1 year of age. We determined that aging decreases vascularization and tumor metastasis in the murine model.
Materials and methods
Mouse procedures. This study was approved by the institutional animal care and use committee before any experiments were performed. C57Bl6J mice were used at 1 month and 1 year of age. Mice were housed in approved environmentally controlled facilities on 12 h light-dark cycles with unlimited access to food and water. Twenty male and female 1 month old and 1 year old mice were dosed orally twice weekly using 25 μl dimethylbenzanthracene (DMBA) dissolved in 20 μl ethanol. The time course and number of tumors were recorded for each animal. Mice were euthanized when any institutional criterion for experimental neoplasia in rodents was met. Euthanized mice were photographed and complete necropsies were performed. A portion of each tumor specimen was flash frozen in liquid nitrogen or fixed in 4% buffered formaldehyde for 16 h at room temperature.
Histopathology and immunohistochemistry. Tumor tissue was dehydrated in an ethanol series, cleared in xylene, and embedded in paraffin. Five micrometer sections were prepared and mounted on poly-L-lysine coated slides. Representative sections were stained with hematoxylin and eosin and histologically evaluated by a pathologist. Immunohistochemical analysis was performed using a commercially available kit (Invitrogen, Carlsbad, CA). Sections were incubated at 60˚C for 30 min and deparaffinized in xylene. Endogenous peroxidase activity was quenched by incubation in a 9:1 methanol/ 30% hydrogen peroxide solution for 10 min at room temperature. Sections were rehydrated in PBS (pH 7.4) for 10 min at room temperature. Sections were blocked with 10% normal serum for 10 min at room temperature followed by incubation with anti-TGF·, HGF, c-met, cyclin A, cyclin D, cyclin E, c-myc, PCNA, and VE-cadherin antibodies (Santa Cruz Biotechnology, Santa Cruz, CA) for 16 h at room temperature. After three washes in PBS, the sections were incubated with secondary antibody conjugated to biotin for 10 min at room temperature. After additional washes in PBS, the sections were incubated with streptavidin conjugated horseradish peroxidase for 10 min at room temperature. Following final washes in PBS, antigen-antibody complexes were detected by incubation with hydrogen peroxide substrate solution containing aminoethylcarbazole chromogen reagent. Slides were rinsed in distilled water, coverslipped using aqueous mounting medium, and allowed to dry at room temperature. The relative intensities of the completed immunohistochemical reactions were evaluated using light microscopy by independent trained observers who were unaware of the mouse genotypes. A scale of 0 to 3 was used to score relative intensity, with 0 corresponding to no detectable immunoreactivity and 1, 2 and 3 equivalent to low, moderate, and high expression, respectively. The number of capillaries per square millimeter in SCCs from each group were counted. Non-parametric data were analyzed by Fisher's exact test.
RNA extraction and gene expression profiling. Total RNA was extracted from microdissected primary and metastatic tumor tissue using a commercially available kit (RNEasy, Qiagen, Valencia, CA). VEGF expression was analyzed by quantitative RT-PCR using primers 5'-GGAAAGGGAAAGG GTCAAAAAC-3' and 5'-TTCTCACATCTGCAAGTACG-3' in 20 mM Tris-HCl (pH 8.3), 1.5 mM MgCl 2 , 63 mM KCl, 0.05% Tween-20, 1 mM EGTA, 50 μM of each dNTP, and 2.5 U Taq DNA polymerase (Roche Applied Science).
Amplification with ß-actin cDNA using primers 5'--3' and 5'--3' as the internal control was carried out by real-time PCR (iCycler, Bio-Rad) using SYBR Green and cycle parameters 94˚C for 25 sec, 55˚C for 1 min, and 72˚C for 1 min.
Individually matched well differentiated primary and metastatic tumor tissue was used in microarray analysis. Three independent samples from each group were used in gene expression analysis. The integrity of rRNA bands was confirmed by Northern gel electrophoresis. Total RNA (10 μg) with spike in controls was reverse transcribed using a T7-oligo(dT) promoter primer in the first strand cDNA synthesis reaction. Following RNase H mediated second strand synthesis, the double stranded cDNA was purified and served as template in the subsequent in vitro transcription reaction. The in vitro transcription reaction was carried out in the presence of T7 RNA polymerase and a biotinylated nucleotide analogue/ ribonucleotide mix for complementary RNA amplification and biotin labeling. The biotinylated complementary RNA targets were then purified, fragmented, and hybridized to Affymetrix GeneChip Expression arrays (Santa Clara, CA). The murine genome 430 2.0 microarray was used to interrogate 39,000 possible transcripts in each sample. After washing, hybridization signals were detected using streptavidin conjugated phycoerythrin. Affymetrix GCOS software was used to generate raw gene expression scores and normalized to the relative hybridization signal from each experiment. All gene expression scores were set to a minimum value of 2 times background determined by GCOS software in order to minimize noise associated with less robust measurements of rare transcripts. Normalized gene expression data were imported into dChip software for hierarchical clustering analysis using the average linkage algorithm. Raw data were analyzed for quality control and the significance of differential gene expression determined by t-test (p<0.05) and ratio analysis (>2-fold).
Results
We characterized HNSCC in wild-type mice when the carcinogenesis protocol was begun at 1 month or 1 year of age. As shown in Fig. 1 , primary HNSCC in the 1 year old group arose at significantly earlier time points on average compared to wild-type mice (18 weeks for the 1 year old mice vs. 22 weeks for 1 month old animals; p<0.03). These data indicate that primary HNSCC in chronologically aged mice develops with significantly decreased latency periods. Chronologically aged mice also demonstrated significantly fewer metastatic lymph nodes per mouse (1.8 positive nodes in the 1 year old group vs. 4.1 nodes in the 1 month old group; p<0.001; Fig. 2 ). These results indicate that SCCs in chronologically aged mice are less metastatic than those in young mice.
Primary HNSCC in wild-type mice which began the induction protocol at 1 year old were much less vascularized ( Fig. 3B ) than those in young mice (Fig. 3A) . The histopathologic appearance of HNSCC in chronologically aged mice was dramatically different from younger animals. While the percentage of well vs. moderately differentiated tumors was similar to that observed in younger mice, areas of necrosis were noted in the primary tumors which correlated with the less vascularized appearance of these cancers in vivo ( Fig. 3C and D). Necrotic tumor tissue was also observed in metastatic lymph nodes in chronologically aged mice (Fig. 3E ). These results indicate that both primary and metastatic HNSCC in chronologically aged mice are less vascularized resulting in necrotic cell death.
We examined expression of cell cycle regulatory proteins in SCC from young and chronologically aged mice by immunohistochemistry. Representative sections are shown in Fig. 4 . Only 10% (2/21) of primary HNSCC from chronologically aged mice overexpressed TGF· (compared to 89% in young mice), EGFR (39% of young mice), cyclin A (56% in young mice), or c-myc. Cyclin E was overexpressed in 30% (6/21) of primary tumors in chronologically aged mice which was similar to that observed in young mice. Cyclin D was overexpressed in 33% (7/21) of primary SCC in chronologically aged mice compared to 44% in young mice. c-met was overexpressed in 48% (10/21) of primary tumors from chronologically aged mice. p16 expression was lost in 90% (19/21) of primary tumors in chronologically aged mice. The number of PCNA positive (proliferating) cells was significantly decreased in SCC from chronologically aged mice (30 vs. 70% in young mice; p<0.01). In metastatic tumors from chronologically aged mice, EGFR was overexpressed in only 8% of cases (3/36). Cyclin A, cyclin B, cyclin E, and c-myc were not overexpressed in metastatic tumors from chronologically aged mice. These results indicate that while primary and metastatic HNSCC from young mice were similar to the human disease with respect to levels of cell cycle regulatory proteins, cancers from chronologically aged mice were dramatically different in expression of these genes.
To determine if decreased vascular endothelial growth factor (VEGF) expression by SCC could account for reduced vascularization of SCC in chronologically aged mice, we performed quantitative RT-PCR on mRNA extracted from tumors in young and aged mice. As shown in Fig. 5A , no significant differences in VEGF expression were observed between these tumors. These results indicate that changes in VEGF expression did not account for reduced vascularization of SCC in chronologically aged mice. However, microvessel density in chronologically aged tumors as determined by VEcadherin labeling was significantly less than those in young mice (79/mm 2 vs. 311/mm 2 ; Fig. 5B ). These results indicate that capillary formation in chronologically aged mice was significantly less than in young mice, suggesting that the response to VEGF was decreased in older animals.
In tumors from chronologically aged mice, we microdissected tissue well away from areas of necrosis. We also used microarray analysis to determine differences between Table I . Gene expression changes between primary SCC in young and old mice (458 genes). Table II . Gene expression changes between metastatic SCC in young and old mice (1235 genes). --------------------------------------------------------------------------------------------------- -Table III . Gene expression changes between primary and metastatic SCC in old mice (1038 genes). 
-----------------------------------------------------------------------------------------------------
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primary and metastatic tumors in mice which began the tumor induction protocol at 1 month old (young) and 1 year old (chronologically aged). As shown in Table I , comparison of primary tumors in young and chronologically aged mice revealed 458 differentially expressed genes. Increased expression of differentiation and adhesion genes was noted: small proline rich protein 3, 31.0-fold; keratin 4, 13.2-fold; desmocollin 1, 7.6-fold; desmocollin 2, 7.5-fold; transglutaminase 3, 5.1-fold. Genes regulating metastasis were differentially regulated in primary tumors from chronologically aged mice (serine peptidase inhibitor clade A, member 9, 5.9-fold; serine peptidase inhibitor clade B, member 12, 5.7-fold; matrix metalloproteinase 9, -5.6-fold; matrix metallopeptidase 13, -6.6-fold; metastasis associated lung adenocarcinoma transcript 1, -7.8-fold; matrix metallopeptidase 11, -8.7-fold). Growth factor receptor expression was inhibited in primary tumors from chronologically aged mice (platelet derived growth factor receptor, -6.0-fold; fibroblast growth factor receptor 1, -5.7-fold; Jagged 1, -5.6-fold). These results indicate that primary tumors from chronologically aged mice were more highly differentiated with increased cellular adhesion and expressed decreased levels of growth factor receptors.
In contrast to the relative relatedness of primary tumors in young and chronologically aged mice, we detected substantially more differentially expressed genes between metastatic SCC in these animals (1235 genes, Table II ). Metastatic tumors from chronologically aged mice were highly differentiated (keratin 6a, 1173.0-fold; keratin 14, 681.9-fold; small proline rich protein 2A, 601.4-fold; keratin 17, 558.6-fold; keratinocyte differentiation associated protein, 320.2-fold; keratin 16, 293.0-fold; keratin 5, 169.6-fold; keratin 1, 72.7-fold; suprabasin, 49.3-fold; keratin 8, 41.6-fold; involucrin, 36.4-fold; keratin 15, 19.2-fold; filaggrin, 12.9-fold; keratin 18, 10.0-fold; vitamin D receptor, 7.7-fold). Genes regulating cellular adhesion were highly upregulated in metastatic HNSCC from chronologically aged mice (plakophilin 1, 281.1-fold; desmoplakin, 221.2-fold; desmoglein 3, 163.7-fold; cadherin 3, 14.8-fold; desmocollin 2, 8.1-fold). Genes regulating metastasis were differentially expressed in metastatic HNSCC from chronologically aged mice (serine peptidase inhibitor, 91.1-fold; snail homolog 2, 22.0-fold; tissue inhibitor of metalloproteinase 1, 11.5-fold; metastasis associated lung adenocarcinoma transcript 1, -59.1-fold). Growth factor signaling was differentially regulated in metastatic SCC from chronologically aged mice (wingless related MMTV integration site 4, 35.7-fold; Jagged 1, 10.8-fold; wingless related MMTV integration site 5A, 9.0-fold; Jagged 2, 8.1-fold; frizzled homolog 2, 5.5-fold; wingless related MMTV integration site 10a, 5.1-fold; leptin receptor -6.0-fold; transforming growth factor ß receptor II, -8.3-fold). Genes regulating cell proliferation were differentially expressed in metastatic HNSCC from chronologically aged mice (cyclin dependent kinase inhibitor 1A, 5.2-fold; cyclin D3, -11.5-fold). Proto-oncogene expression was decreased in metastatic HNSCC from chronologically aged mice (Vav1 oncogene, -5.1-fold; SloanKettering viral oncogene homolog, -5.2-fold). The Forkhead family of transcription factors was differentially expressed in these tumors (Forkhead box Q1, 22.4-fold; Forkhead box C1, 14.2-fold; Forkhead box P1, -5.6-fold). These results indicate that metastatic tumors in chronologically aged mice were more differentiated with increased cellular adhesion and less proliferative than their counterparts from young mice.
We compared primary and metastatic SCC in chronologically aged mice and identified 1038 differentially expressed genes (Table III) . Metastatic SCC was substantially less differentiated compared to primary tumors in these mice (epithelial membrane protein 2, -5.5-fold; transglutaminase 5, -6.1-fold; keratin 1, -6.4-fold; cornifelin, -7.0-fold; suprabasin, -7.0-fold; keratin 10, -16.6-fold; filaggrin, -16.9-fold; transglutaminase 3, -49.5-fold; small proline rich like 9, -53.6-fold; loricin, -107.2-fold). Cellular adhesion genes also were downregulated in metastatic SCC compared to primary tumors (periplakin, -8.0-fold; desmoglein 1 ß, -9.1-fold; desmocollin 2, -10.0-fold; desmoplakin, -22.7-fold; desmocollin 3, -32.0-fold; desmoglein 1 ·, -47.6-fold; desmocollin 1, -54.5-fold). Growth factors and receptors were downregulated in metastatic compared to primary SCC in chronologically aged mice (fibroblast growth factor receptor 2, -6.3-fold; epithelial mitogen, -9.8-fold; epiregulin, -9.9-fold; amphiregulin, -10.1-fold). Genes involved in cell signaling pathways were upregulated (serine/threonine kinase 10, 9.6-fold; leptin receptor, 8.8-fold; phosphoinositide 3-kinase, 5.8-fold; signal transducer and activator of transcription 1, 5.5-fold). Genes regulating metastasis and migration were differentially regulated in metastatic HNSCC from chronologically aged mice (dedicator of cytokinesis, 17.0-fold; tissue inhibitor of metalloproteinase 3, 7.7-fold; serine peptidase inhibitor clade A member 10, 6.4-fold; vinculin, -5.4-fold). These results indicate that metastatic tumors in chronologically aged mice are less differentiated and demonstrate less cellular adhesion and increased intracellular signaling than corresponding primary tumors.
Discussion
Despite association of diminished DNA repair with premature aging, we did not observe decreased expression of DNA repair genes in tumor tissue from chronologically aged mice. These results suggest that accumulation of low level DNA damage during the first year of mouse lifespan may predispose the animals to primary HNSCC development during chemical carcinogenesis. Additionally, HNSCC induced in 1 year old mice was poorly vascularized and developed areas of necrosis, which may reduce the number of metastatic clones. The number of metastatic cervical lymph nodes in these chronologically aged mice was statistically lower than other groups. Metastatic tumors in cervical lymph nodes also showed areas of necrosis. Neither primary nor metastatic tumors from the different groups of mice expressed lower levels of angiogenic factors such as vascular endothelial growth factor. These results suggest that capillary endothelium in chronologically aged mice may be less responsive to angiogenic factors resulting in decreased tumor vascularization and increased cell death. Previous studies have demonstrated decreased angiogenic response in aged organisms.
A number of transcription factors were differentially regulated in the aging model of HNSCC. The TWIST gene which has been shown to enhance metastasis in many types of cancer was downregulated in primary HNSCC in chrono-logically aged mice (21, 22) . The Runx3 transcription factor is a major tumor suppressor in many tumor types including human HNSCC where high expression is correlated with better prognosis (23, 24) . p63 which is required for proliferation and differentiation of epithelial cells was dramatically upregulated in tumors from chronologically aged mice (25) . The FoxP1 forkhead transcription factor is downregulated in multiple cancer types (26) , and its expression also was decreased in metastatic tumors from chronologically aged mice. The oncogenic transcription factor PAX5 is upregulated in human HNSCC (27) , and its expression also was increased in metastatic tumors in chronologically aged mice. The Jumonji domain containing transcriptional repressors Jarid1a and Jarid2 have potential tumor suppressor function (28) , and their expression is inhibited in tumors from chronologically aged mice. The basonuclin transcription factor is markedly upregulated in basal cell carcinoma in epidermis (29) , and also in metastatic tumor cells from chronologically aged mice. Elements of the Wnt signaling pathway were altered in HNSCC such as upregulation of Wnt4, Wnt10a, and frizzled homolog 2 in metastatic tumors from chronologically aged mice. Members of the nuclear hormone receptor family such as peroxisome proliferator activated receptor Á was upregulated in primary SCC in chronologically aged mice, but downregulated in metastatic tumors from chronologically aged mice. These results indicate that HNSCC in our mouse model recapitulates many of the alterations in transcription factor gene expression found in human cancer.
